‘Aspirin resistance’ behind lack of clinical aspirin benefit on heart attacks
May 5th, 2010 - 3:27 pm ICT by ANIWashington, May 5 (ANI): A researcher at Florida Atlantic University had earlier shown that aspirin prevents a first heart attack.
Based on the landmark, physicians Health Study (PHS), Dr. Charles H. Hennekens, Sir Richard Doll Research Professor in the Charles E. Schmidt College of Biomedical Science, proposed that individuals who develop a heart attack on aspirin do so, at least in part, because they are not taking the drug or they are taking non-steroidal anti-inflammatory drugs (NSAIDs) which inhibit the clinical benefit of aspirin.
Previous studies had suggested that the lack of clinical benefit was due to “aspirin resistance.”
Subjects in the PHS were 22,071 apparently healthy U.S. male physicians, aged 40-84 at entry, without prior history of cardiovascular disease, cancer or other major illnesses.
Participants assigned to aspirin who were non-compliant (did not take the 180 study pills per year) had no significant reduction in risk of myocardial infarction. Furthermore, participants assigned to aspirin who self-selected the use of NSAIDs had no significant reduction in risk of myocardial infarction.
All of these observations contribute to the formulation of the researchers’ hypothesis that non-adherence or NSAIDs use explains the lack of clinical benefit of aspirin on first myocardial infarction which has been attributed to “aspirin resistance.”
Their observations also imply that the interrelationship between laboratory measurements used to indicate inadequate anti-platelet responses to aspirin and “treatment failure” requires evaluation in randomized trials designed to test this hypothesis.
“Aspirin non-response is a clinical reality, but “aspirin resistance” remains a theoretical possibility which requires further research,” said Hennekens.
The study has been published in the May issue of the American Heart Journal. (ANI)
- High and low dose aspirin can protect heart - Mar 27, 2012
- Aspirin may cut the risk of pancreatic cancer - Apr 05, 2011
- Why folic acid won't prevent a heart attack - Feb 03, 2011
- Aspirin safer than warfarin in preventing stroke: Study - May 03, 2012
- New aspirin curbs 11 kinds of cancer, shrinks tumours - Mar 09, 2012
- Aspirin 'cuts bowel cancer risk' - Sep 16, 2010
- Aspirin cuts cancer risk - Mar 21, 2012
- Colder weather 'increases heart attack risk' - Aug 11, 2010
- Painkillers shoot up death risk in heart attacks - May 10, 2011
- Exposure to low-dose radiation 'ups cancer risk' - Feb 08, 2011
- Morning heart attacks 'likely to be most fatal than later in the day' - Apr 28, 2011
- More strokes, fewer heart attacks with carotid stents: Study - Oct 12, 2010
- Seasonal flu vaccine 'lowers first heart attack risk' - Sep 21, 2010
- Intense light reduces heart attack risks - Apr 26, 2012
- Aspirin 'cuts stroke risk in patients with peripheral artery disease' - May 13, 2009
Tags: american heart journal, anti inflammatory drugs, biomedical science, charles e schmidt, charles e schmidt college, charles h hennekens, clinical benefit, clinical reality, first heart attack, florida atlantic university, history of cardiovascular disease, laboratory measurements, male physicians, myocardial infarction, non steroidal anti inflammatory drugs, physicians health, platelet responses, sir richard doll, theoretical possibility, treatment failure